Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Heart Transplantation

  Free Subscription


Articles published in Transpl Immunol

Retrieve available abstracts of 27 articles:
HTML format



Single Articles


    February 2024
  1. ALAM A, van Zyl JS, Patel R, Jamil AK, et al
    Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation.
    Transpl Immunol. 2024 Feb 5:102009. doi: 10.1016/j.trim.2024.102009.
    PubMed     Abstract available


    September 2023
  2. KUCZAJ A, Warwas S, Zakliczynski M, Pawlak S, et al
    Does the induction immunotherapy (basiliximab) influence the early acute cellular rejection index after orthotopic heart transplantation?- Preliminary assessment report.
    Transpl Immunol. 2023 Sep 29:101937. doi: 10.1016/j.trim.2023.101937.
    PubMed     Abstract available


    August 2023
  3. ALAM A, Van Zyl J, Mckean S, Abdelrehim A, et al
    Rejection! Or is it? Correlation among molecular microscope diagnostic system, histopathology and clinical judgement following heart transplantation.
    Transpl Immunol. 2023 Aug 28:101924. doi: 10.1016/j.trim.2023.101924.
    PubMed     Abstract available


  4. TESZAK T, Assabiny A, Kiraly A, Tarjanyi Z, et al
    Extracorporeal photopheresis in the treatment of cardiac allograft rejection: A single-centre experience.
    Transpl Immunol. 2023;79:101853.
    PubMed     Abstract available


  5. CREMEN S, Santiago RM, Robinson MW, Gallagher TK, et al
    Biomarkers of biological aging in recipients of solid organ transplantation and clinical outcomes: A scoping review.
    Transpl Immunol. 2023;79:101851.
    PubMed     Abstract available


    March 2023
  6. CHOU-WU E, Kemna M, Ross S, Youngs D, et al
    Association of MICA and AT1R antibodies with antibody mediated rejection and cardiac allograft vasculopathy in a pediatric heart transplant recipient.
    Transpl Immunol. 2023 Mar 6:101811. doi: 10.1016/j.trim.2023.101811.
    PubMed     Abstract available


    December 2022
  7. GRILLE-CANCELA Z, Barge-Caballero E, Suarez-Fuentetaja N, Domenech-Garcia N, et al
    Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes.
    Transpl Immunol. 2022 Dec 3:101771. doi: 10.1016/j.trim.2022.101771.
    PubMed     Abstract available


    November 2022
  8. ZHOU Y, Huang X, Liu L, Zeng F, et al
    Effect of Wuzhi preparations on tacrolimus in CYP3A5 expressers during the early period after transplantation: A real-life experience from heart transplant recipients.
    Transpl Immunol. 2022 Nov 21:101748. doi: 10.1016/j.trim.2022.101748.
    PubMed     Abstract available


    October 2022
  9. OSCHERWITZ M, Nguyen HQ, Raza SS, Cleveland DC, et al
    Will previous palliative surgery for congenital heart disease be detrimental to subsequent pig heart xenotransplantation?
    Transpl Immunol. 2022;74:101661.
    PubMed     Abstract available


    September 2022
  10. MCCUNE TR, Bray RA, Baran DA, Toepp AJ, et al
    Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    Transpl Immunol. 2022;75:101722.
    PubMed     Abstract available


  11. GAVROY B, Timmermans T, Van Caenegem O, Mastrobuoni S, et al
    Significance of HLA-matching and anti-HLA antibodies in heart transplant patients receiving induction therapy?
    Transpl Immunol. 2022;75:101706.
    PubMed     Abstract available


  12. YANG BQ, Vader JM, Lambert DS, Petrella R, et al
    COVID-19 in orthotopic heart transplant recipients and association with donor specific antibodies.
    Transpl Immunol. 2022 Sep 10:101712. doi: 10.1016/j.trim.2022.101712.
    PubMed     Abstract available


    July 2022
  13. LU L, Shi M, Qiu J, Shi Z, et al
    ZBTB20 regulates cardiac allograft rejection through NFsmall ka, CyrillicB-mediated inflammation in mouse heart transplantation.
    Transpl Immunol. 2022 Jul 21:101676. doi: 10.1016/j.trim.2022.101676.
    PubMed     Abstract available


    March 2022
  14. CHAU VQ, Feinman J, Fullin K, Mahmood K, et al
    De novo human leukocyte antigen allosensitization patterns in patients bridged to heart transplantation using left ventricular assist devices.
    Transpl Immunol. 2022;72:101567.
    PubMed     Abstract available


    December 2021
  15. CHAIDAROGLOU A, Armenis I, Gkouziouta A, Bonios MJ, et al
    The effect of paracorporeal pulsatile biventricular assist devices on allosensitization in adults: A comparison with left ventricular assist devices.
    Transpl Immunol. 2021;69:101477.
    PubMed     Abstract available


    October 2021
  16. MATAR AJ, Crepeau RL, Duran-Struuck R
    Non-invasive imaging for the diagnosis of acute rejection in transplantation: The next frontier.
    Transpl Immunol. 2021;68:101431.
    PubMed     Abstract available


  17. YANG L, Ma J, He Q, Li X, et al
    Immutol regulates CD4(+)Tregs, CD8(+)Tregs and pDCs via IDO signaling pathway to induce immune tolerance in rat heart allograft transplant.
    Transpl Immunol. 2021;68:101393.
    PubMed     Abstract available


    August 2021
  18. SCHWEIGER M, Erdil T, Di Bernardo S, Balmer C, et al
    Use of induction therapy in pediatric heart transplant recipients in Switzerland - Analysis of the Swiss national database.
    Transpl Immunol. 2021 Aug 2:101443. doi: 10.1016/j.trim.2021.101443.
    PubMed     Abstract available


  19. FUJIMOTO K, Uchida K, Yin E, Zhu J, et al
    Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
    Transpl Immunol. 2021;67:101405.
    PubMed     Abstract available


    June 2021
  20. XI Y, Ma Y, Xie B, Di A, et al
    Vitamin D3 combined with antibody agents suppresses alloreactive memory T-cell responses to induce heart allograft long-term survival.
    Transpl Immunol. 2021;66:101374.
    PubMed     Abstract available


    May 2021
  21. PALMIERI V, Mansueto G, Coscioni E, Maiello C, et al
    Novel biomarkers useful in surveillance of graft rejection after heart transplantation.
    Transpl Immunol. 2021;67:101406.
    PubMed     Abstract available


    April 2021
  22. PAZDERNIK M, Bedanova H, Chen Z, Kautzner J, et al
    Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis.
    Transpl Immunol. 2021;65:101340.
    PubMed     Abstract available


  23. EMOTO S, Shibasaki S, Nagatsu A, Goto R, et al
    Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4(+)CD25(+)Foxp3(+) T cells and ameliorates allograft rejection in an antigen-specific manner.
    Transpl Immunol. 2021;65:101338.
    PubMed     Abstract available


    February 2021
  24. LU J, Liu Y, Wang W, Li P, et al
    Knockdown of miR-146a in regulatory T cells suppresses heart transplantation rejection in mice by increasing autophagy.
    Transpl Immunol. 2021;65:101372.
    PubMed     Abstract available


  25. FRITZ NM, Stamminger T, Ramsperger-Gleixner M, Kuckhahn AV, et al
    Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model.
    Transpl Immunol. 2021;64:101359.
    PubMed     Abstract available


    October 2020
  26. LI C, Wang X, Yuan F, Zhao Z, et al
    MiR-669b-3p regulates CD4(+) T cell function by down-regulating indoleamine-2, 3-dioxygenase.
    Transpl Immunol. 2020;62:101320.
    PubMed     Abstract available


    June 2020
  27. TIMOFEEVA OA, Alvarez R, Pelberg J, Yoon E, et al
    Serum dilutions as a predictive biomarker for peri-operative desensitization: An exploratory approach to transplanting sensitized heart candidates.
    Transpl Immunol. 2020;60:101274.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Heart Transplantation is free of charge.